Ποια είναι η τιμή για PT Merck Tbk (MERK)

Η τιμή για PT Merck Tbk (MERK) είναι $0.23475574

Ποια είναι η κεφαλαιοποίηση αγοράς για PT Merck Tbk (MERK)

Η κεφαλαιοποίηση αγοράς για PT Merck Tbk (MERK) είναι $105.17M

PT Merck Tbk (MERK) Τιμή και Κεφαλαιοποίηση Αγοράς

Operating in Indonesia, PT Merck Tbk is a pharmaceutical company focused on the production and distribution of medicinal products. Its business operations are structured into three main divisions: Biopharma, Consumer Health, and an 'Others' segment. The company provides healthcare solutions addressing a broad spectrum of therapeutic areas, including conditions related to the cardiovascular system, metabolism, oncology, endocrinology, fertility, and neurodegenerative disorders, alongside general pharmaceutical offerings. Furthermore, PT Merck Tbk is actively involved in the discovery, development, production, and commercialization of both pharmaceutical and biological prescription drugs. These medicines target specific conditions such as colorectal and head and neck cancers, multiple sclerosis, infertility, growth hormone imbalances, diabetes, and various thyroid conditions like hyperthyroidism and hypothyroidism. Beyond its core pharmaceutical activities, the company also engages in property leasing and management. Established in 1970 and headquartered in East Jakarta, Indonesia, the company was originally known as PT Merck Indonesia Tbk before adopting its current name, PT Merck Tbk, in June 2002. It operates as a subsidiary of Merck Holding GmbH.

Η τιμή για MERK	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$11,632.57 $105.17M	NVDA	$5.211T	+4,955,079.46%
$10,149.03 $105.17M	AAPL	$4.547T	+4,323,129.23%
$9,291.28 $105.17M	GOOG	$4.162T	+3,957,749.81%
$8,019.66 $105.17M	MSFT	$3.593T	+3,416,070.14%
$6,234.08 $105.17M	AMZN	$2.793T	+2,655,458.38%

Η τιμή για MERK

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$11,632.57 $105.17M